Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Blazquez-Perez A, San Miguel R, Mar J. Cost-effectiveness analysis of triple therapy with protease inhibitors in treatment-naive hepatitis C patients. PharmacoEconomics 2013; 31(10): 919-931 Indexing Status Subject indexing assigned by NLM MeSH Age Factors; Antiviral Agents /administration & Clinical Trials as Topic; Cost-Benefit Analysis; Disease Progression; Drug Therapy, Combination; Genotype; Hepacivirus /genetics /isolation & Hepatitis C, Chronic /drug therapy /economics; Humans; Interferon-alpha /administration & Interleukins /genetics; Markov Chains; Middle Aged; Oligopeptides /administration & Polyethylene Glycols /administration & Proline /administration & Protease Inhibitors /administration & Quality-Adjusted Life Years; Recombinant Proteins /administration & Ribavirin /administration & Spain; derivatives /economics /therapeutic use; dosage /analogs & dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use; dosage /economics /therapeutic use; purification AccessionNumber 22013041095 Date bibliographic record published 31/10/2013 |